PH12021552915A1 - Crystalline form of sofpironium bromide and preparation method thereof - Google Patents
Crystalline form of sofpironium bromide and preparation method thereofInfo
- Publication number
- PH12021552915A1 PH12021552915A1 PH1/2021/552915A PH12021552915A PH12021552915A1 PH 12021552915 A1 PH12021552915 A1 PH 12021552915A1 PH 12021552915 A PH12021552915 A PH 12021552915A PH 12021552915 A1 PH12021552915 A1 PH 12021552915A1
- Authority
- PH
- Philippines
- Prior art keywords
- crystalline form
- sofpironium bromide
- preparation
- diastereomer
- sofpironium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/147—Saturated compounds having only one carboxyl group and containing —CHO groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pyrrole Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962851880P | 2019-05-23 | 2019-05-23 | |
| PCT/JP2020/020210 WO2020235665A1 (en) | 2019-05-23 | 2020-05-22 | Crystalline form of sofpironium bromide and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH12021552915A1 true PH12021552915A1 (en) | 2022-04-04 |
Family
ID=72146250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH1/2021/552915A PH12021552915A1 (en) | 2019-05-23 | 2020-11-26 | Crystalline form of sofpironium bromide and preparation method thereof |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US20220298108A1 (https=) |
| EP (1) | EP3972955A4 (https=) |
| JP (2) | JP6748329B1 (https=) |
| KR (1) | KR20220011671A (https=) |
| CN (1) | CN114008023B (https=) |
| AU (1) | AU2020277881B2 (https=) |
| BR (1) | BR112021023241A2 (https=) |
| CA (1) | CA3139948A1 (https=) |
| CL (1) | CL2021003047A1 (https=) |
| CO (1) | CO2021017456A2 (https=) |
| IL (1) | IL288285B1 (https=) |
| MX (1) | MX2021014163A (https=) |
| MY (1) | MY206154A (https=) |
| PH (1) | PH12021552915A1 (https=) |
| SG (1) | SG11202111678WA (https=) |
| TW (2) | TWI838531B (https=) |
| WO (1) | WO2020235665A1 (https=) |
| ZA (1) | ZA202109514B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220298108A1 (en) * | 2019-05-23 | 2022-09-22 | Kaken Pharmaceutical Co., Ltd. | Crystalline form of sofpironium bromide and preparation method thereof |
| EP4213158A1 (en) | 2020-11-13 | 2023-07-19 | Ahead Biocomputing, Co. Ltd | Information processing device, information processing method, recording medium recording information processing program, and information processing system |
| CN115925603B (zh) * | 2022-11-29 | 2025-07-22 | 山东齐都药业有限公司 | 索吡溴铵的制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7927613B2 (en) * | 2002-02-15 | 2011-04-19 | University Of South Florida | Pharmaceutical co-crystal compositions |
| US7417147B2 (en) * | 2005-11-10 | 2008-08-26 | Bodor Nicholas S | Soft anticholinergic zwitterions |
| ATE529399T1 (de) * | 2005-11-10 | 2011-11-15 | Nicholas S Bodor | Sanfte anticholinerge ester |
| MX357741B (es) * | 2012-07-06 | 2018-07-23 | Laboratorios Senosiain S A De C V Star | Nuevas formas sólidas de inhibidores de fosfodiesterasa tipo 5. |
| US9512166B2 (en) * | 2012-09-05 | 2016-12-06 | Amri Ssci, Llc | Cocrystals of progesterone |
| US20150259283A1 (en) * | 2014-03-13 | 2015-09-17 | Brickell Biotech, Inc. | Formulation for soft anticholinergic analogs |
| US10282282B2 (en) * | 2016-06-29 | 2019-05-07 | Synopsys, Inc. | Automated HTTP user flows simulator |
| EP3494106B1 (en) * | 2016-08-02 | 2022-07-20 | Journey Medical Corporation | Processes for making, and methods of using, glycopyrronium compounds |
| US20220298108A1 (en) * | 2019-05-23 | 2022-09-22 | Kaken Pharmaceutical Co., Ltd. | Crystalline form of sofpironium bromide and preparation method thereof |
-
2020
- 2020-05-22 US US17/611,158 patent/US20220298108A1/en active Pending
- 2020-05-22 KR KR1020217041385A patent/KR20220011671A/ko not_active Ceased
- 2020-05-22 CA CA3139948A patent/CA3139948A1/en active Pending
- 2020-05-22 BR BR112021023241A patent/BR112021023241A2/pt unknown
- 2020-05-22 EP EP20809754.3A patent/EP3972955A4/en active Pending
- 2020-05-22 SG SG11202111678WA patent/SG11202111678WA/en unknown
- 2020-05-22 MY MYPI2021006212A patent/MY206154A/en unknown
- 2020-05-22 TW TW109117164A patent/TWI838531B/zh active
- 2020-05-22 MX MX2021014163A patent/MX2021014163A/es unknown
- 2020-05-22 AU AU2020277881A patent/AU2020277881B2/en active Active
- 2020-05-22 CN CN202080034880.8A patent/CN114008023B/zh active Active
- 2020-05-22 TW TW112144978A patent/TWI870116B/zh active
- 2020-05-22 WO PCT/JP2020/020210 patent/WO2020235665A1/en not_active Ceased
- 2020-05-22 IL IL288285A patent/IL288285B1/en unknown
- 2020-05-22 JP JP2020089283A patent/JP6748329B1/ja active Active
- 2020-08-06 JP JP2020133620A patent/JP7605598B2/ja active Active
- 2020-11-25 US US17/105,376 patent/US11566000B2/en active Active
- 2020-11-26 PH PH1/2021/552915A patent/PH12021552915A1/en unknown
-
2021
- 2021-06-30 US US17/364,445 patent/US11584715B2/en active Active
- 2021-11-18 CL CL2021003047A patent/CL2021003047A1/es unknown
- 2021-11-24 ZA ZA2021/09514A patent/ZA202109514B/en unknown
- 2021-12-20 CO CONC2021/0017456A patent/CO2021017456A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2020189856A (ja) | 2020-11-26 |
| IL288285B1 (en) | 2026-02-01 |
| TW202110796A (zh) | 2021-03-16 |
| CA3139948A1 (en) | 2020-11-26 |
| SG11202111678WA (en) | 2021-11-29 |
| US20210395197A1 (en) | 2021-12-23 |
| JP2020189839A (ja) | 2020-11-26 |
| AU2020277881A1 (en) | 2021-12-09 |
| CN114008023A (zh) | 2022-02-01 |
| ZA202109514B (en) | 2023-12-20 |
| US11566000B2 (en) | 2023-01-31 |
| CL2021003047A1 (es) | 2022-09-20 |
| AU2020277881B2 (en) | 2025-03-06 |
| CO2021017456A2 (es) | 2022-01-17 |
| US11584715B2 (en) | 2023-02-21 |
| EP3972955A4 (en) | 2023-07-05 |
| TW202411205A (zh) | 2024-03-16 |
| KR20220011671A (ko) | 2022-01-28 |
| CN114008023B (zh) | 2024-02-09 |
| IL288285A (en) | 2022-01-01 |
| BR112021023241A2 (pt) | 2022-01-04 |
| TWI870116B (zh) | 2025-01-11 |
| MX2021014163A (es) | 2022-01-04 |
| JP6748329B1 (ja) | 2020-08-26 |
| TWI838531B (zh) | 2024-04-11 |
| EP3972955A1 (en) | 2022-03-30 |
| JP7605598B2 (ja) | 2024-12-24 |
| US20220298108A1 (en) | 2022-09-22 |
| MY206154A (en) | 2024-12-02 |
| WO2020235665A1 (en) | 2020-11-26 |
| US20210171460A1 (en) | 2021-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202109514B (en) | Crystalline form of sofpironium bromide and preparation method thereof | |
| WO2004014902A3 (en) | Compounds having an activity at metabotropic glutamate receptors | |
| BG108318A (en) | Carboxamide-substituted phenylurea derivatives and method for the production and use thereof as medicaments | |
| SE0200920D0 (sv) | Novel compounds | |
| GEP20094664B (en) | Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors | |
| TW200616995A (en) | Novel compounds | |
| MXPA04004498A (es) | Derivados de n-adamantilmetil e intermediarios como composiciones farmaceuticas y procesos para su preparacion. | |
| MY139303A (en) | Novel aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof | |
| SE9901875D0 (sv) | Novel compounds | |
| MXPA05013752A (es) | Procedimiento e intermediarios para la preparacion de (1r,2s,5s)-6,6-dimetil-3-azabiciclo[3,1,0]exan-2-carboxilatos o sales de los mismos. | |
| NO20051223L (no) | Oksadiazoler som modulatorer av metabotropisk glutamat reseptor-5. | |
| MY138086A (en) | Novel urea derivative as vanilloid receptor-1 antagonist | |
| MX2022006470A (es) | Tiromimeticos novedosos. | |
| PH12021551873A1 (en) | Hydroxypyridoxazepines as nrf2 activators | |
| TW200505505A (en) | Process for modifying drug crystal formation | |
| SE0302192D0 (sv) | Novel compounds | |
| JO2493B1 (en) | New phenyl azatidinone with improved physical properties and methods of preparation of drugs containing it and its uses | |
| MXPA03008675A (es) | Camsilato de amlodipina novedoso y metodo para su preparacion. | |
| GEP20094576B (en) | New cyrstalline form iii of agomelatine, a process for its preparation and pharmaceutical compositions containing it | |
| MX2021003232A (es) | Inhibidores de o-glicoproteina-2-acetamido-2-desoxi-3-d-glucopiran osidasa. | |
| TW200639156A (en) | New compounds | |
| CA3155875A1 (en) | BIARYL COMPOUND SUBSTITUTED BY SULFO OR CORRESPONDING SALT, METHOD FOR PREPARATION AND USE | |
| JPS55147258A (en) | 44aryloxyy and 44arylthioo33phenylpiperidine derivatives* their manufacture and their use as medicine | |
| TW200605888A (en) | Novel compounds | |
| MX2021004379A (es) | Nuevos derivados amino-pirimidonil-piperidinilo, un proceso para su preparacion y composiciones farmaceuticas que los contienen. |